Genes with synergistic relationship with IDH1 mutations in glioma such as ATRX have been previously reported [34], representing a glioma subgroup distinct from those with co-mutations of IDH1 with CIC and FUBP1 mutations [46] (Fig. 2f). This evidence concerns the gene IDH1 and central nervous system cancer.